trending Market Intelligence /marketintelligence/en/news-insights/trending/dvfrnsqyiksohgzj-4egnw2 content esgSubNav
In This List

Auris regains compliance with one Nasdaq listing requirement

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Auris regains compliance with one Nasdaq listing requirement

Switzerland's Auris Medical Holding AG regained compliance with Nasdaq's minimum bid price requirement of $1 per share.

However, the pharmaceuticals company is yet to regain compliance with the stock exchange's minimum $35 million market value of listed securities.

Auris has until July 10 to regain compliance with that condition.